It is of great importance that YTHDC2 expression differs in different molecular subtypes of cancers, including ACC, BRCA, COAD, HNSC, LGG, PCPG, PRAD, STAD and UCEC, suggesting that it could be more meaningful for YTHDC2 study focusing on a certain molecular subtype of cancers. The gene discussed is YTHDC2; the disease is cancer.